We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ...

Iovance stock drops 90% despite historic approval for Amtagvi. Click here for a full investment analysis of IOVA stock.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $3 ...

In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report), with a price target of $18.00. The company’s ...